Drug Profile
M-TMCD
Latest Information Update: 29 Apr 2002
Price :
$50
*
At a glance
- Originator Nonindustrial source
- Class Antiepileptic drugs; Neuroprotectants
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Epilepsy
Most Recent Events
- 11 May 1999 New profile
- 11 May 1999 Preclinical development for Epilepsy in Israel (Unknown route)